Sysmex ADR Other Operating Income or Expenses 2016-2024 | SSMXY
Sysmex ADR annual/quarterly other operating income or expenses history and growth rate from 2016 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Sysmex ADR other operating income or expenses for the quarter ending September 30, 2024 were $M, a 100% decline year-over-year.
- Sysmex ADR other operating income or expenses for the twelve months ending September 30, 2024 were $0.003B, a 68.35% decline year-over-year.
- Sysmex ADR annual other operating income or expenses for 2024 were $0.007B, a 5.47% decline from 2023.
- Sysmex ADR annual other operating income or expenses for 2023 were $0.008B, a 139.87% decline from 2022.
- Sysmex ADR annual other operating income or expenses for 2022 were $-0.019B, a 350.52% decline from 2021.
| Sysmex ADR Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $7 |
| 2023 | $8 |
| 2022 | $-19 |
| 2021 | $8 |
| 2020 | $7 |
| 2019 | $4 |
| 2018 | $-10 |
| 2017 | $8 |
| 2016 | $0 |
| Sysmex ADR Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | $0 |
| 2023-06-30 | $1 |
| 2022-06-30 | $1 |
| 2021-06-30 | $1 |
| 2020-06-30 | $2 |
| 2019-06-30 | $1 |
| 2018-06-30 | $5 |
| 2017-06-30 | $1 |
| 2016-06-30 | $5 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.450B | $3.197B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $199.883B | 24.39 |
| Intuitive Surgical (ISRG) | United States | $186.649B | 97.58 |
| Edwards Lifesciences (EW) | United States | $42.814B | 27.19 |
| Alcon (ALC) | Switzerland | $41.161B | 27.54 |
| IQVIA Holdings (IQV) | United States | $35.414B | 19.51 |
| IDEXX Laboratories (IDXX) | United States | $33.479B | 39.43 |
| DexCom (DXCM) | United States | $30.662B | 46.18 |
| Waters (WAT) | United States | $21.866B | 32.33 |
| STERIS (STE) | Ireland | $19.984B | 23.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.343B | 0.00 |
| Hologic (HOLX) | United States | $16.281B | 17.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.998B | 13.34 |
| Globus Medical (GMED) | United States | $11.143B | 28.22 |
| Penumbra (PEN) | United States | $9.211B | 90.22 |
| Masimo (MASI) | United States | $9.025B | 43.67 |
| Teleflex (TFX) | United States | $8.316B | 13.26 |
| Glaukos (GKOS) | United States | $8.253B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.433B | 25.13 |
| PROCEPT BioRobotics (PRCT) | United States | $4.340B | 0.00 |
| Veracyte (VCYT) | United States | $3.134B | 94.05 |
| Inari Medical (NARI) | United States | $3.033B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.533B | 14.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.354B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.318B | 17.61 |
| TransMedics (TMDX) | United States | $2.232B | 70.75 |
| Elekta AB (EKTAY) | Sweden | $2.095B | 18.83 |
| Integra LifeSciences Holdings (IART) | United States | $1.776B | 9.28 |
| RxSight (RXST) | United States | $1.393B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.285B | 0.00 |
| Artivion (AORT) | United States | $1.177B | 78.00 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Paragon 28 (FNA) | United States | $0.897B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.728B | 12.37 |
| AxoGen (AXGN) | United States | $0.722B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.90 |
| IRadimed (IRMD) | United States | $0.696B | 37.63 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.660B | 0.00 |
| SiBone (SIBN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.554B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.506B | 26.63 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.490B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.411B | 22.23 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.346B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Nevro (NVRO) | United States | $0.139B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Neuronetics (STIM) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |